Timely HAART initiation may pave the way for a better viral control

BACKGROUND: When to initiate antiretroviral therapy in HIV infected patients is a diffcult clinical decision. Actually, it is still a matter of discussion whether early highly active antiretroviral therapy (HAART) during primary HIV infection may influence the dynamics of the viral rebound, in case...

Descripción completa

Detalles Bibliográficos
Autores principales: Paci, Paola, Martini, Federico, Bernaschi, Massimo, D'Offizi, Gianpiero, Castiglione, Filippo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058048/
https://www.ncbi.nlm.nih.gov/pubmed/21362195
http://dx.doi.org/10.1186/1471-2334-11-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058048/
https://www.ncbi.nlm.nih.gov/pubmed/21362195
http://dx.doi.org/10.1186/1471-2334-11-56

Ejemplares similares